Mayra Guerrero, MD @MayraGuerreroMD Twitter profile

Last Seen Profiles

@stwmaniax

@earthtojun

@joongdoker

@rie_mabuchi

@radenbusy

@killaqueen21

@sienengelis

@awax120

@MRibnek

@MoorNookPark

@Meilleurrr

@jaayaamaarie

@astrid_morenoor

@irreplaceablesi

@IWILLSTILLRISE

@Kavethamwedzine

@carolyn89hauman

@PrieztBami

@TheReal_Tweezy1

@bokeplokalmalam

@jandakembangstw

@yonceebabyy

@shigeyan3800

@vidoakdame

@yonceebabyy

@Bistrong_

@PAmizero

@lapeerstudentco

@sosowhosews

@Kharsa

@bokeplokalmalam

@Roblox

@vpusoko

@bokeplokalmalam

@stwmaniax

Mayra Guerrero, MD

@MayraGuerreroMD

4 years

25 years later… Same husband, same dress, 1st son (Hector, 23) 1st year Med Student, 2nd son (Eric, 17) accepted at Univ of Chicago. To all women… Yes, you can be a busy Interventional Cardiologist and have a family! Just find the right husband :)

99

231

3K

Mayra Guerrero, MD

@MayraGuerreroMD

5 years

Had the honor of doing 1st STEMI case in a pt with suspected COVID at our institution today. Sick, requiring intubation in cath lab. 1.-I felt peaceful knowing we were well prepared & protected. If I get infected, then nothing can stop this virus, were as protected as can be. 1/

31

123

935

Mayra Guerrero, MD

@MayraGuerreroMD

2 years

Starting 1st TAVR today with all women except 1 fellow. Interv fellow & Surgery fellow are women. I was 1st woman ever in my cardiology fellowship, very different today. Great change in just 1 lifetime! Progress changing the Face of Cardiology. Happy Women’s Day!!! @MayoClinicCV

15

68

653

Mayra Guerrero, MD

@MayraGuerreroMD

3 years

The ultimate Multitask: bike while you review CT scans or emails. Highly recommended! ⁦ @MayoClinicCV ⁩

15

68

550

Mayra Guerrero, MD

@MayraGuerreroMD

4 years

New COVID pandemic phase..."Cut your own hair”! I knew I had to do a TAVR & a TS MViV today. Hair too long to contain properly under surgical cap. Business closed= no hairdressers. So… I cut my own hair! Not a good hair cut but TAVR, STEMI and challenging TS MViV went well :)

32

7

395

Mayra Guerrero, MD

@MayraGuerreroMD

5 years

Came to Cath reading conference today & found all cardiology fellows at conf are women. What a change!...I was the first female cardiology fellow in my program... all female at conference today! The face of Cardiology is changing! #WIC #ACCFIT @MayoClinicCV

19

46

387

Mayra Guerrero, MD

@MayraGuerreroMD

5 months

One of the happiest moments of my life! To see my son graduate with honors from Medical School (University of Illinois College of Medicine, Chicago).❤️ And was Vice-President of the Class Board for all 4 years! Ready for his next chapter… Internal Medicine Residency at

59

6

372

Mayra Guerrero, MD

@MayraGuerreroMD

11 months

All women TEER with PASCAL device today!!! Technical success after 1 PASCAL Ace, excellent results thanks to the strong work from 2 female Structural Interventional Cardiology Fellows @MayoClinicCV ! @WomenAs1

14

30

354

Mayra Guerrero, MD

@MayraGuerreroMD

7 months

The most important Match Day for me! My Son’s! Future Internal Medicine Resident at McGaw Medical Center of Northwestern University Feinberg School of Medicine in Chicago! Congratulations Hector M. Cajigas!!! @fgcmacho #UICOMMatch2024 @MayoClinicCV @NU_IntMed

27

6

353

Mayra Guerrero, MD

@MayraGuerreroMD

5 years

One of my favorite TAVR cases: female structural fellow, female interventional fellow, female cardiac surgery fellow, female nurses, female interventional cardiologist... doing TAVR in a female patient!!! Our male cardiac surgeon was outnumbered but worked well with us :)

2

31

332

Mayra Guerrero, MD

@MayraGuerreroMD

3 months

The Ultimate TAVR experience!!! All Women TAVR + All from Diverse Backgrounds! From right to left: Female patient + Graduating Female SHD Interventional Fellow + Female Cardiac Surgeon who recently joined our practice + Me extremely happy🥰+ Female 3rd Year Med Student who wants

17

31

331

Mayra Guerrero, MD

@MayraGuerreroMD

4 years

One of my favorite TAVR cases from 2020: female structural fellow, female interventional fellow, female surgery resident, female IC, female nurses and female pt! Happy National Women Physicians Day!!! ⁦ @MayoClinicCV ⁩

8

13

286

Mayra Guerrero, MD

@MayraGuerreroMD

6 years

I finally entered "Twitter world". It's easier to fix a heart valve than setting up a Twitter account. Not an easy task, had to use 3 different browsers until it finally worked. Dee Dee, thank you for encouraging me and for your help!

42

6

230

Mayra Guerrero, MD

@MayraGuerreroMD

7 months

No words to describe the feeling… Returning to my Alma Mater 3 decades later to receive the ”Meritus 2023” lifetime achievement award in Health Sciences at Universidad Autonoma de Baja California, Mexico. Eternally grateful to God, my family, friends and teachers. This is for

31

15

216

Mayra Guerrero, MD

@MayraGuerreroMD

5 years

And 3.- I felt honored to be part of this team & honored to know if I die from this, would be the most meaningful death one can have… dying helping others. I understand soldiers now, it’s a calling. To my friends on the frontlines… Thank you and stay safe! @MayoClinicCV 3/

12

18

211

Mayra Guerrero, MD

@MayraGuerreroMD

4 years

We present a review of image guidance for MViV, MViR, ViMAC and PVL closure. I hope you find it helpful. @MayoClinicCV Imaging Guidance for Transcatheter Mitral Valve Intervention on Prosthetic Valves, Rings, and Annular Calcification

5

69

209

Mayra Guerrero, MD

@MayraGuerreroMD

1 year

Final MITRAL Trial 5Y outcomes LBCT @ #EuroPCR 2023. MViV, MViR & ViMAC with Sapien 3 was associated with sustained improvement of HF symptoms & QoL @ 5 years. THV function remained stable in all groups. Excellent survival @ 5 years in MViV, lower in MViR & ViMAC. @MayoClinicCV

8

71

196

Mayra Guerrero, MD

@MayraGuerreroMD

5 years

2.- I felt grateful to work at an institution with great leadership that protects physicians and resources to provide health care workers with double mask, N95 mask first and a regular mask on top of that. @MayoClinicCV 2/

5

12

166

Mayra Guerrero, MD

@MayraGuerreroMD

9 months

Our first “All Women” Mitral PVL Closure! Female patient + Female TEE imaging expert + Female Interv cardilogy fellows and attenting + Female nurse and cath lab tech. Patient doing well and happy after successful Mitral PVL closure 🙂 @MayoClinicCV

11

20

159

Mayra Guerrero, MD

@MayraGuerreroMD

5 years

I have decorated many Christmas trees in my life, but this one is my favorite so far. A prosthetic heart valves tree to celebrate progress in this field. Notice the presents under the tree... different THVs, even a couple ViVs :) Merry Christmas and Happy New Year! @MayoClinicCV

4

32

158

Mayra Guerrero, MD

@MayraGuerreroMD

4 years

One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 THV via @JAMACardio part of @JAMANetwork We found low mortality: 5.4% at 30 days & 16.7% at 1-year. Transseptal lower mortality than TA access at 1 year (15.8% vs 21.7%, p=0.03) @MayoClinicCV

3

50

156

Mayra Guerrero, MD

@MayraGuerreroMD

5 years

Packed house at the first WISH Women in Structural Heart symposium! I wish my grandmother was still alive to see this. She wanted to be a doctor but her father didn’t let her because is wasn’t “appropriate for a woman”. Two generations later…All women panel! Thank you @crfheart !

5

32

151

Mayra Guerrero, MD

@MayraGuerreroMD

5 years

I arrived to my office this morning and found this beautiful poster from a good friend, doctor and extraordinarily talented artist... Dr. Rana Awdish @RanaAwdish @hectorrcajigas Totally unexpected, what a way to start the day! Thank you!!!

5

8

150

Mayra Guerrero, MD

@MayraGuerreroMD

2 years

Finally! A MAC ICD code! Thank you all who helped me get the proposed code submitted & approved! Please use I34.81 moving forward in your daily practice. This will help us adequately categorize these patients and conduct research 🙂 @MayoClinicCV

3

23

144

Mayra Guerrero, MD

@MayraGuerreroMD

5 years

Do you think everybody who cannot stay home as recommended during COVID pandemic... Should wear a mask when going out? Some countries are doing that. Could that make a difference in the US or other countries?

36

12

132

Mayra Guerrero, MD

@MayraGuerreroMD

2 years

4-Year Outcomes MITRAL Trial #ESCCongress : MViV all-cause death @ 4Y only 10%, higher in MViV & MViR (66.7%) but sustained THV performance & symptom improvement in survivors in all groups! @MayoClinicCV @MayoClinic @WomenAs1

0

36

133

Mayra Guerrero, MD

@MayraGuerreroMD

2 years

Fortunate to be part of this amazing group of Cardiologists and future Cardiologists ⁦ @MayoClinicCV ⁩

1

7

127

Mayra Guerrero, MD

@MayraGuerreroMD

5 years

“Transseptal MViV: A Step-by-Step Guide from Pre-procedural Planning to Post-procedural Care” made it to the top 20 Most read papers in 2017-2018. Thank you all for downloading our paper!

6

32

128

Mayra Guerrero, MD

@MayraGuerreroMD

2 years

Congratulations ⁦ @drpaulfriedman ⁩ for the Distinguished Inventor Award at Mayo Clinic 2022!!! What an honor to have you as our Chair for the Department of CV Medicine. A privilege to be part of your team! ⁦ @MayoClinicCV ⁩

3

15

122

Mayra Guerrero, MD

@MayraGuerreroMD

8 months

I wasn’t prepared to hear this, truly heart breaking 💔 😞 At least he can rest in peace knowing his mission is accomplished, he changed the world. @MayoClinicCV

Dr Roxana Mehran

@Drroxmehran

8 months

My heart is broken. A true legend no longer on earth, forever in our ❤️❤️Your legacy will never be forgotten. You saved unmeasurable number of lives, brought us the unthinkable innovation in our field. One in a trillion!!! Dearest Alain RIP 😞😞😞😞💔💔💔

10

41

423

4

10

118

Mayra Guerrero, MD

@MayraGuerreroMD

4 years

COVID-19 vaccine!!! I never thought I would be so happy getting a vaccine!!! 🙂👍

4

1

117

Mayra Guerrero, MD

@MayraGuerreroMD

4 years

2-Year outcomes of MITRAL Trial presented at London Valves. All-cause mortality at 2 years in ViMAC arm (39.3%) was similar to TAVR in PARTNER I Trial (43.3%). Not bad for an EFS. Next steps… MITRAL II Pivotal Trial!!! 110 Transseptal ViMAC & 100 Med Rx (NCT 04408430).

5

30

115

Mayra Guerrero, MD

@MayraGuerreroMD

3 years

Predictors of LVOTO After ViMAC: Analysis of TMVR in MAC Global Registry. LVOT % reduction >63%, LVOT area <371mm2, Neo-LVOT area <173 mm2, Neo-LVOT area index <127mm2 & Virtual THV to Septum (VTS) distance <5.5mm. @MayoClinicCV

Predictors of Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replace...

Graphical Abstract Background: Several studies have evaluated preprocedural imaging predictors of left ventricular outflow tract obstruction (LVOTO) after transcatheter mitral valve replacement. The...

www.ahajournals.org

1

33

113

Mayra Guerrero, MD

@MayraGuerreroMD

2 years

I'm truly honored and humbled. Thank you @CiticMexico for the Academic achievement award and for allowing to share my personal journey in Interventional Cardiology from my hometown in Mexico to @MayoClinic

CITIC

@CiticMexico

2 years

Fue un honor reconocer a la Dra. Mayra Guerrero con el Premio CITIC 2022 a la Trayectoria Académica, gracias por su inspirador mensaje a las mujeres y hombres que han luchado por alcanzar sus sueños y nunca rendirse. #CITIC2022

13

15

144

13

9

114

Mayra Guerrero, MD

@MayraGuerreroMD

4 years

A Cardiac Computed Tomography–Based Score to Categorize Mitral Annular...

9

44

112

Mayra Guerrero, MD

@MayraGuerreroMD

5 years

Happy to share few slides with MITRAL trial 1-Year outcomes presented at EuroPCR today. 1-year mortality in MViV was 3.3%, really low! For MViR was 26.7% and for MAC 33%, not much different than MitraClip in TVT Registry (24.7% DMR and 31.5% FMR). A step in the right direction.

2

51

111

Mayra Guerrero, MD

@MayraGuerreroMD

3 years

MITRAL Trial MAC Arm: Pts treated with TS ViMAC had 6.7% 30-day mortality, was lower than predicted by the STS score (mean 9.9%, median 6.2%). At 1 year, ViMAC was associated with improved symptoms & stable THV performance. @MayoClinicCV @JACCJournals

4

27

106

Mayra Guerrero, MD

@MayraGuerreroMD

5 months

We evaluated 820 patients treated with TS MViR using the Sapien 3/Ultra/RESILIA THVs between Aug 2015 and Dec 2022 who were enrolled in the STS/ACC TVT Registry. We found a significant reduction in MR and sustained improvement in symptoms at 1 year. Mean mitral gradients were

2

28

110

Mayra Guerrero, MD

@MayraGuerreroMD

1 year

Today is the 10th Anniversary of the FIH Transseptal ViMAC. Thankful for what we have learned together, and more importantly… for your friendship and collaboration. Thank you all! With deepest gratitude🙏 @MayoClinicCV

3

27

109

Mayra Guerrero, MD

@MayraGuerreroMD

3 years

Electric driverless “Med City Mover” can transport people in downtown Rochester…We took the opportunity to ride between consults at 2 different Mayo Clinic buildings. The future is here! ⁦ @MayoClinicCV ⁩ ⁦ @MayoClinic ⁩

4

6

105

Mayra Guerrero, MD

@MayraGuerreroMD

2 years

I bought a car in AZ because I need to visit there very very often. My AZ license plates… the new ICD Code for MAC: I34.81. Goes well with my current MN License plates: TMVR and my prior IL plates: I CATH 🙂

2

0

105

Mayra Guerrero, MD

@MayraGuerreroMD

1 year

MViV, MViR & ViMAC with Sapien 3 associated with sustained improvement of HF symptoms & QoL @ 5 years. Stable THV function in all groups. MViV had excellent survival @ 5 years, lower survival in MViR & ViMAC. Thank you all collaborators! @MayoClinicCV

2

34

101

Mayra Guerrero, MD

@MayraGuerreroMD

2 years

Forgot to tell you: Last week, I arrived to Cath Lab and saw the schedule...5 Interv Cardiologsits working that day (3 women, 2 men)...60% Female IC doing procedures that day! Only @MayoCliniCV ! Welcome Claire @claireraph !

0

3

100

Mayra Guerrero, MD

@MayraGuerreroMD

30 days

Our superstar fellow @mahmoud_ismayl presenting @ESCardio presenting “TAVR vs SAVR in patients younger than 65 years: Analysis from the National Inpatient Sample Database”. TAVR is increasingly performed among patients aged 50-64 years and is associated with lower in-hospital

2

12

90

Mayra Guerrero, MD

@MayraGuerreroMD

2 years

The CLASP IID trial #TCT2022 : PASCAL not inferior to MitraClip in high surgical risk patients. Low adverse events in both groups. Similar survival. ⁦ @MayoClinicCV ⁩

1

16

87

Mayra Guerrero, MD

@MayraGuerreroMD

4 months

Congratulations @Mahmoud_Ismayl for a great presentation #NYValves2024 ! The utilization of TAVR in patients aged 50 to 64 years in the US is increasing rapidly! Compared to SAVR, TAVR in this younger population was associated with lower complication rates and lower Inhospital

0

10

83

Mayra Guerrero, MD

@MayraGuerreroMD

1 year

On behalf of P3 investigators, we share “1-Year Outcomes of PARTNER 3 MViV Intermediate Risk Registry” presented today @ #TVT2023 . Primary Endpoint of All-Cause Death or Stroke at 1 year, was ZERO! Sustained improvement of symptoms, QoL & stable THV function @ 1Y. @MayoClinicCV

1

19

81

Mayra Guerrero, MD

@MayraGuerreroMD

3 months

After a long day of work… Why not spend an evening together having fun with a Zumba class? We deserve some bonding time, and we get to burn few calories at the same time!😃. Thank you @MayoClinicCV leadership for supporting Women In Cardiology! 🙏And a big thank you to my female

5

6

79

Mayra Guerrero, MD

@MayraGuerreroMD

3 years

In this study of pts with severe MAC treated with TMVR ViMAC, pts with severe Pulm HTN at baseline had similar outcomes than pts without Pulm HTN. Severe PH should not be a reason to deny TMVR in MAC. @MayoClinicCV @hectorrcajigas

The impact of pulmonary hypertension on outcomes of transcatheter mitral valve replacement in...

Objectives To assess the impact of pulmonary hypertension (PH) on outcomes of patients with severe mitral annular calcification (MAC) undergoing transcatheter mitral valve replacement (TMVR). Back...

onlinelibrary.wiley.com

4

19

78

Mayra Guerrero, MD

@MayraGuerreroMD

2 years

Retirement luncheon for a wonderful mentor, role model and friend. The legend ⁦ @davidrholmes2 ⁩ retires to start a new chapter as a freshman at college. My deepest respect and admiration ⁦ @davidrholmes2 ⁩ ⁦ @MayoClinicCV ⁩

3

7

79

Mayra Guerrero, MD

@MayraGuerreroMD

6 months

We are looking for good candidates 🙂 Please consider this great opportunity to obtain training in SHD interventions! @MayoClinicCV @MayoClinicCVS

Mayo Clinic Rochester Cardiology Fellows

@MayoCVFellows

6 months

To Interventional Cardiology Program Directors and Education Coordinators: We have an unexpected opening for our Mayo Clinic Interventional Cardiology Fellowship in Structural Heart Disease for 2024-25 in Rochester, Minnesota.

5

63

156

2

14

77

Mayra Guerrero, MD

@MayraGuerreroMD

5 years

@saraceciliamtz In this order: usual cloth surgical cap, N95 mask, disposable surgical cap to cover cloth cap, disposable mask to protect N95, shoe covers, scrub, 1st pair sterile gloves, sterile reusable good quality surgical gown, 2nd pair sterile gloves, dressed in control room, entered lab.

6

13

77

Mayra Guerrero, MD

@MayraGuerreroMD

8 months

Happy “National Women Physicians Day ”Feb 3rd!!! It commemorates the bday of Dr. Elizabeth Blackwell who in 1949 became the 1st woman to receive a medical degree in the US. Celebrating with photos from “National Wear Red Day”! @MayoClinicCV

1

9

77

Mayra Guerrero, MD

@MayraGuerreroMD

2 years

The best way to start the day at AHA scientific sessions 2022… 15 mile bike ride at the beautiful Lake Shore Drive! I love #AHA2022 ! And I love Chicago! ❤️ ⁦ @MayoClinicCV ⁩

1

2

75

Mayra Guerrero, MD

@MayraGuerreroMD

1 year

⁦ @AbdullahAlabcha ⁩ presenting his work on staging MAC disease according to extra-mitral Cardiac damage at #TVT2023 . MAC pts with more advanced MAC stages have higher mortality. Congratulations! ⁦ @MayoClinicCV ⁩ ⁦ @MayoCVFellows ⁩

3

9

74

Mayra Guerrero, MD

@MayraGuerreroMD

4 years

Great! Our CT-Based MAC score paper to categorize MAC severity & predict valve embolization during ViMAC made it to the Top 8 CT papers of the year presented at SCCT 2020! Thank you @ToddVillinesMD ! MAC score 6 or less = high risk, MAC score 7 or more= low risk. @MayoClinicCV

Ritu Thamman MD

@iamritu

4 years

Top 8 #Yessct studies at #Scct2020 by @ToddVillinesMD #6 . CT based MAC score for ViV embolization/migration If score >= 9 no emboliz/migra If score <=6 ⬆️risk (OR 5.9) @MayraGuerreroMD @DeeDeeWangMD @JACCJournals

1

15

32

1

14

73

Mayra Guerrero, MD

@MayraGuerreroMD

2 years

MITRAL Trial 2 y outcomes. Survival in MViV 93.3%! Mortality higher in ViMAC 39.3% & MViR 50% (for reference 2Y TAVR death PARTNER 1 was 43%). MViV, MViR & ViMAC associated with improved symptoms, QoL & stable THV function. @MayoClinicCV

JACC Journals

@JACCJournals

2 years

For severe MAC, failed annuloplasty rings or malfunctioning valves, balloon-expandable transcatheter aortic valves in the mitral position improves symptoms, #QOL , and valve function: #JACC #MITRAL #TAVR @EleidMack @MayraGuerreroMD

0

12

42

1

20

73

Mayra Guerrero, MD

@MayraGuerreroMD

3 months

Looking forward to working with our new cardiology fellows. Welcome to the Mayo Clinic family!!!🙏❤️

Mayo Clinic Rochester Cardiology Fellows

@MayoCVFellows

3 months

Welcome to the new Cardiology fellows 💓🫀🏩! Our family got a little bigger! Our first meet-and-greet just wrapped up - we can’t wait to see you at orientation and around the @MayoClinic campus! WELCOME 🥰!

0

11

101

1

4

70

Mayra Guerrero, MD

@MayraGuerreroMD

5 years

It took years of work, but we are now able to demonstrate that Transseptal MViV is associated with better outcomes than Transapical MVIV. Thank you all that contributed to this team effort!

Yael L. Maxwell

@TCTMD_Yael

5 years

Transcatheter mitral ViV procedures, esp those done via transseptal access, are associated w/ low mortality & adverse event rates plus improved QoL through 1 yr in high-risk patients #TCT2019 @MayraGuerreroMD @bonowr @ajaykirtane @PinakShahMD @BadhwarVinay

0

6

12

2

11

70

Mayra Guerrero, MD

@MayraGuerreroMD

1 year

Join us at #TVT2023 for a live TMVR case using the Innovalve under the TWIST trial ⁦ @MayoClinicCV ⁩ ⁦ @EleidMack ⁩ ⁦ @ChetRihal ⁩

1

7

68

Mayra Guerrero, MD

@MayraGuerreroMD

4 years

@SharonneHayes @DrJMieres @biljana_parapid @gina_lundberg @DrLaxmiMehta @KBerlacher @HeartBobH @hvanspall @robertshor This is wrong! Reminds me when a Chief of IC @ a famous Hosp in CA told me 18 years ago "I would like to accept U in our fellowship but I can't because U R Mexican". Ironically, that institution tried to recruit me 2 weeks ago to be Chief of IC as he is retiring. I said No thx.

5

7

67

Mayra Guerrero, MD

@MayraGuerreroMD

1 year

Celebrating a successful TS TMVR case with Innovalve system #TVT2023 ⁦ @MayoClinicCV ⁩ ⁦ @ChetRihal ⁩ ⁦ @EleidMack ⁩ ⁦ @AbdullahAlabcha ⁩

0

4

66

Mayra Guerrero, MD

@MayraGuerreroMD

5 months

I’m so proud of our fellows! Strong work! Congratulations!!! 👍

Mayo Clinic Rochester Cardiology Fellows

@MayoCVFellows

5 months

Proud of the strong ❤️‍🔥 @MayoCVFellows representation @SCAI #SCAI2024 in Long Beach, CA! 🌄 Congrats!! @TDonisan , @KarolQuelal , @Mahmoud_Ismayl @MayoClinicCV @MayoClinic #CardioX @nandananavekar @mwcullen @MayraGuerreroMD @AttaBehfar @rajivxgulati

2

7

52

1

4

66

Mayra Guerrero, MD

@MayraGuerreroMD

6 years

It was a great honor to sit with him as part of the panel to discuss these extremely important trials. Awesome to see history being made and a true privilege being part of the discussion.

Kimberly Atianzar MD FACC FASE

@KimAtianzar

6 years

Dr. Eugene Braunwald on both Low risk TAVR results! @sameergafoor @DrToniyaSingh @TCTMD_Yael #ACC19 #StructuralHeart @MayraGuerreroMD @DeeDeeWangMD #ACCWIC @moiz_hafiz @AdedotunOgunsua @drgauravrana @GBaqueroMD @nkakouros @DrAAACardioVasc @MoJadelrab1 @crfshj @PatrycjaGalazka

1

42

108

2

7

65

Mayra Guerrero, MD

@MayraGuerreroMD

5 years

We have a lot of work to do to increase diversity in medicine, particularly in Cardiology. Please share any ideas you have that can help us close this gap.

Cardiovascular Research Foundation

@crfheart

5 years

On this new episode of #ClinicianInsider , @MayraGuerreroMD and @_WayneBatchelor discuss the wide-ranging effects of the gap in #diversityinmedicine :

0

2

9

4

20

64

Mayra Guerrero, MD

@MayraGuerreroMD

4 years

Thank you Hector for amazing 25 years!!!

2

64

Mayra Guerrero, MD

@MayraGuerreroMD

3 years

Thank you for reading and citing our paper which made it to the the list of most cited in Circ Interventions! @MayoClinicCV @CircIntv

9

4

64

Mayra Guerrero, MD

@MayraGuerreroMD

2 years

Imagine all the people (Cardiology) living life in peace (Healthcare Equity), You may say I’m a dreamer But I’m not the only one I hope someday YOU’LL JOIN US And the world (Cardiology) will be as One.🎼 Happy Feb 14 and BHM! ❤️🙂 @MayoClinicCV @MayoEquity @ACCinTouch @WomenAs1

1

10

64

Mayra Guerrero, MD

@MayraGuerreroMD

2 years

LBCT #TCT2022 “TEER for MR and Cardiogenic Shock” analysis from TVT Registry by ⁦ @adnanalkhouli ⁩ : Lower mortality and hospitalization for heart failure rate in successful TEER cases. Randomized trial ongoing in Canada. ⁦ @MayoClinicCV ⁩

1

16

63

Mayra Guerrero, MD

@MayraGuerreroMD

3 years

MITRAL Trial MViV Arm: TS MViV in high-risk pts (median STS 9.4%) had low complications & low 3.3% mortality at 1 year. MViV was associated with improved symptoms & stable THV performance. @MayoClinicCV @JACCJournals

3

17

61

Mayra Guerrero, MD

@MayraGuerreroMD

1 year

Thank you @ACCInTouch for the wonderful #ACCIMProgram to increase #ACCDiversity and change #TheFaceOfCardiology !!! We had a wonderful session today at the Hispanic/Latinx Cohort! Thank you to all our speakers and ACC!!! @MayoClinicCV

2

7

58

Mayra Guerrero, MD

@MayraGuerreroMD

3 years

Of 5,502 pts with MAC detected by TTE, 357 had severe MV dysfunction, 108 had MV intervention and 249 did not. Pts with MAC & MVD who underwent MV intervention had better survival than pts without intervention. @MayoClinicCV .

2

17

58

Mayra Guerrero, MD

@MayraGuerreroMD

2 years

TWIST EFS with Innovalve presented by ⁦ @ChetRihal ⁩ @CRTmeeting 2023. Technical success 100%, low risk of LVOTO, resolution of MR, EF improved. ⁦ @MayoClinicCV ⁩

1

12

57

Mayra Guerrero, MD

@MayraGuerreroMD

3 years

A real honor to be part of this team! As I work to help recruit the best fellows and advance innovation and academic productivity… our focus is to increase Equity, Diversity & Inclusion @MayoClinicCV

Mayo Clinic Rochester Cardiology Fellows

@MayoCVFellows

3 years

Announcing... the Mayo Clinic CV Fellowship Dream Team! A special welcome to Dr. @AttaBehfar , Research APD, and Dr. @MayraGuerreroMD , Recruitment and Academic Affairs APD. We are excited for the vision they bring to our education leadership! @nandananavekar @mwcullen @panithayaC

3

7

66

1

54

Mayra Guerrero, MD

@MayraGuerreroMD

10 months

In this State of the Art paper, we were invited to provide an overview of TMVR in native MV including MAC: we cover challenges, Who is a candidate?, CT analysis, Clinical Trials, outcomes and future directions. @marinaurenaa @PhilipLurz @MayoClinicCV

EuroIntervention

@EuroInterventio

10 months

This State of the Art provides an overview on transcatheter mitral valve replacement for the treatment of native mitral valve disease, including patients with severe annular calcification, with a glimpse into the future of these therapies. #EAPCI

0

28

45

0

17

55

Mayra Guerrero, MD

@MayraGuerreroMD

3 years

Please join us tomorrow at ESC on this important debate: TMVr/TMVR for second at MR - Routine use or Niche? Pro: Mayra Guerrero vs Con: Michael Borger. Noon Paris time, 5 am Central time. ⁦ @MayoClinicCV ⁩ ⁦ @GreggWStone ⁩ ⁦⁦ @vonBardelebenRS ⁩

2

9

56

Mayra Guerrero, MD

@MayraGuerreroMD

5 years

2 Year Clinical & Echo Outcomes in PARTNER 3 Low-risk Randomized Trial presented at virtual LBCT #ACC20 session today: 1ry Endpoint (death, stroke or rehosp) at 1 year lower with TAVR, but higher valve thrombosis between 1 and 2 years seen in TAVR patients (2.6% vs 0.7% at 2y).

1

33

54

Mayra Guerrero, MD

@MayraGuerreroMD

11 months

Congratulations @AbdullahAlAbcha for presenting #TCT2023 !!! Patients with MAC who have MV Dysfunction often have more advanced MAC stages according to extra-mitral cardiac damage. And more advanced stages are associated with higher mortality! @MayoClinicCV

2

7

54

Mayra Guerrero, MD

@MayraGuerreroMD

5 years

This paper focuses on the early experience of these procedures in the US. Contemporary outcomes are even better!

CircInterventions

@CircIntv

5 years

30-Day Outcomes of Transcatheter Mitral Valve Replacement (valve-in-valve,valve-in-ring,valve in MAC. Improved symptoms with stable valve performance by @MayraGuerreroMD and colleagues @AHAScience @CircAHA @CircOutcomes @AHAMeetings #ACCFIT #AHAjournals

0

26

50

3

7

53

Mayra Guerrero, MD

@MayraGuerreroMD

4 months

Simply excellent! What a wonderful meeting! Superb content, amazing city and a great opportunity to connect with colleagues!!! I can’t wait to #NYValves2025 ! ❤️ Thank you @crfheart team for this opportunity! 🙏

Cardiovascular Research Foundation

@crfheart

4 months

#NYValves2024 exceeded all expectations! A heartfelt thank you to our attendees, supporters, program directors, and faculty for making this first meeting a remarkable success. 🙏✨ See you next year at #NYValves2025 ! 🚀 #CardioX #CardioTwitter #CardioEd

2

14

67

0

8

51

Mayra Guerrero, MD

@MayraGuerreroMD

1 year

A real honor to share this interview at @CITICMexico #CITIC2023 with Dr. Jose Antonio Condado @jacardio who did the First-in-Human TEER with MitraClip! The first in man TEER was in Venezuela. Thank you CITIC 2023 and Dr. Julieta Morales! @modanira @MayoClinicCV

0

4

51

Mayra Guerrero, MD

@MayraGuerreroMD

4 years

Awesome Tendyne in MAC Live Case @TCTConnect from University of Virginia!!! Congratulations!

0

8

50

Mayra Guerrero, MD

@MayraGuerreroMD

3 years

The all-female led @TheLancet Commission, comprised of 17 experts from 11 countries, presenting its findings during a plenary session now the @ACCinTouch ’s #ACC21 . @MayoClinicCV Help us share the Lancet manuscript in this link. @WomenAs1

0

17

51

Mayra Guerrero, MD

@MayraGuerreroMD

2 years

A very special Mayo Clinic WIC get together at AHA 2002. What a way to wrap up AHA Scientific Sessions! ⁦ @MayoClinicCV ⁩ Cheers!!!

0

3

50

Mayra Guerrero, MD

@MayraGuerreroMD

6 years

I found the International Newsweek magazine at the Vienna airport. Very proud to see the Mayo Clinic Hospital in Rochester was ranked as #1 in the world. Nice to see Chet Rihal in the magazine. To find this in Austria... truly international news! Proud to be part of the team!!!

0

5

49

Mayra Guerrero, MD

@MayraGuerreroMD

2 years

So proud of our research fellow ⁦ @AtefehGho ⁩ presenting ⁦ @ACCinTouch ⁩ #ACC2023WCC outcomes of iatrogenic ASD closure vs no closure after TS TMVR (MITRAL trial). No significant difference in outcomes between groups after adjusting comorbidities. ⁦ @MayoClinicCV ⁩

2

5

49

Mayra Guerrero, MD

@MayraGuerreroMD

1 year

VALOR-HCM trial results presented by @DesaiMilindY @ESC2023 , HOCM pts who received Mavacamten had significant sustained improvement of LVOT gradient and NYHA class. Avoided need for Septal Reduction Rx in 90%. Impressive!

Mayo Clinic CV

@MayoClinicCV

1 year

Are you aware of the groundbreaking science on valve disease and hypertrophic cardiomyopathy? Join the breaking science session at 4:30pm, where @MayraGuerreroMD from @MayoClinic will cover these topics more in detail. Do not miss out on this valuable discussion. #ESC2023

0

11

1

10

50

Mayra Guerrero, MD

@MayraGuerreroMD

2 years

Impressive presentation by ⁦ @drpaulfriedman ⁩ at the 2022 Samsung-Mayo Clinic Heart Symposium in Seoul Korea on ECG AI algorithms. ECG can predict patient’s age, sex and LV Dysfuntion. Now Apple Watch can predict LV Dysfuntion! Very powerful tool!!! ⁦ @MayoClinicCV ⁩

2

9

49

Mayra Guerrero, MD

@MayraGuerreroMD

1 year

On behalf of my P3 coinvestigators, I invite you to be the first ones to see the “1-Year Outcomes of PARTNER 3 MViV Intermediate Risk Registry”. Please join us today at 11:45 am room 106 at #TVT2023 . @MayoClinicCV @ChrisMalaisrie @AlanZajarias

2

6

48

Mayra Guerrero, MD

@MayraGuerreroMD

4 years

ESC today: Of 24,415 pts (all comers) who underwent echo evaluation, the prevalence of MAC was 22%. Pts with MAC had higher mortality than pts without MAC. Among pts with MAC & MV dysfunction, adjusted mortality was two-fold higher compared to those without MAC. Good job Nahoko!

1

3

47

Mayra Guerrero, MD

@MayraGuerreroMD

3 years

MITRAL Trial MViR Arm: 30-Day mortality 6.7% (lower than predicted by STS score of 8.7%), at 1 year was 23.3% (similar to MitraClip in TVT Registry). Symptoms improved & THV performance remained stable. @MayoClinicCV @JACCJournals

3

15

48

Mayra Guerrero, MD

@MayraGuerreroMD

2 months

We enrolled Intermediate surgical risk patient in the Mitral Valve-in-Valve Registry of PARTNER 3 trial. A total fo 50 patients were treated with TS MViV using the Sapien 3 THV, mean age 70 years, 54% female and mean STS-PROM of 4.1%. Technical success was 98%. The 26 mm S3 and

1

8

48

Mayra Guerrero, MD

@MayraGuerreroMD

5 years

I hope this is just the beginning. See you there!!!

Vivian Ng

@DrVivianNg

5 years

Proud to announce that we will be having the inaugural #WISH (women in structural heart) symposium at TCT2019!! ⁦ @hahn_rt ⁩ ⁦ @MayraGuerreroMD ⁩ ⁦ @TCTMD ⁩ ⁦ @HeartValveCntr ⁩ ⁦ @WomenAs1 ⁩ ⁦ @Drroxmehran ⁩

10

30

113

2

3

45

Mayra Guerrero, MD

@MayraGuerreroMD

3 months

@BirkhoelzerS Exactly, well said. I am not asking for an ALL WOMEN Cath Lab ALL the time. All I want is to show our female residents and fellows that IT'S OK to have an ALL WOMEN and from DIVERSE Backgrounds team once in a while, it doesn't have to be all men as it was in prior years. I want

4

46

Mayra Guerrero, MD

@MayraGuerreroMD

5 years

Thank you, but would like to clarify it's evolving thanks to many people. Great teams working on this: MITRAL, SITRAL, LAMPOON, SUMMIT, APOLLO...hopefully MITRAL II. Can't wait to see what comes next! @MayoClinicCV

Juan Terré, MD, FACC, FSCAI 🇦🇷🇺🇸

@Juan_Terre

5 years

Great talk from @MayraGuerreroMD #CRT2020 - Evolving algorythm in the treatment of Severe Mitral Valve Disease and severe MAC.

0

11

0

2

45

Mayra Guerrero, MD

@MayraGuerreroMD

2 years

Thank you @ACCinTouch , @DrQuinCapers4 & #ACCDiversity for supporting #ACCIMProgram ! An honor to be part of the Hispanic/Latinx Cohort! Working together to change #TheFaceOfCardiology  IM residents: remember… Nobody belongs here more than you!🙂 @MayoClinicCV

Quinn Capers, IV

@DrQuinnCapers4

2 years

Say “Hello” to the future of 🫀: approximately 60 Hispanic IM residents who aspire to be cardiologists. Our pledge: to demystify the specialty and provide mentorship to help you be a competitive fellowship applicant. @ACCinTouch is serious about diversifying our specialty!

12

41

324

1

3

45

Mayra Guerrero, MD

@MayraGuerreroMD

2 months

An important highlight of SOLACI 2024. Fantastic meeting of @WomenAs1 and #WIN and MIL! Thank you @solaci_congress !!! And can’t wait to see this amazing group at our next meetings including SOLACI 2025 in Mexico 🇲🇽!

Dr Roxana Mehran

@Drroxmehran

2 months

The progress of women in Interventional Cardiology ⁦ @solaci_congress ⁩ 🇦🇷so proud of these amazing women ⁦ @womenAs1 ⁩ #WIC

2

11

124

3

5

44

Mayra Guerrero, MD

@MayraGuerreroMD

3 years

!ear Red!!Happy Wear Red Day!!! Once we eliminate disparities, someday we will Wear Red just to remember. In the meantime, we have work to do!!! W

0

4

43

Mayra Guerrero, MD

@MayraGuerreroMD

1 year

Thank you @ACCInTouch for the wonderful #ACCIMProgram to increase #ACCDiversity and change #TheFaceOfCardiology !!! We had a wonderful session today at the Hispanic/Latinx Cohort! Thank you to all our speakers and ACC!!! @MayoClinicCV

0

8

44

Mayra Guerrero, MD

@MayraGuerreroMD

3 years

The Lancet Women and Cardiovascular Disease Commision: Reducing the Global Burden by 2030. One of the most important projects of our lifetime! A call to action, we all are part of the solution! @MayoClinicCV @WomenAs1 @TheLancet @Drroxmehran @ACCinTouch

0

14

43